ERRβ: Validating a novel target for triple-negative breast cancer

被引：0
|
作者：
Fernandez, Aileen I. [1 ]
Graham, Garrett [1 ]
Gyorffy, Balazs [2 ]
Cavalli, Luciane R. [1 ]
Riggins, Rebecca B. [1 ]
机构：
[1] Georgetown Univ, Washington, DC USA
[2] Semmelweis Univ, Budapest, Hungary
来源：
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION | 2020年 / 29卷 / 06期
关键词：
D O I：
10.1158/1538-7755.DISP18-C103
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
C103
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [1] ERRβ: Validating a novel target for triple negative breast cancer
    Fernandez, Aileen I.
    Graham, Garrett
    Gyorffy, Balazs
    Cavalli, Luciane
    Riggins, Rebecca B.
    CANCER RESEARCH, 2017, 77
  • [2] ERRα Is a Marker of Tamoxifen Response and Survival in Triple-Negative Breast Cancer
    Manna, Subrata
    Bostner, Josefine
    Sun, Yang
    Miller, Lance D.
    Alayev, Anya
    Schwartz, Naomi S.
    Lager, Elin
    Fornander, Tommy
    Nordenskjold, Bo
    Yu, Jane J.
    Stal, Olle
    Holz, Marina K.
    CLINICAL CANCER RESEARCH, 2016, 22 (06) : 1421 - 1431
  • [3] Identifying novel cancer stem cell target for triple-negative breast cancer
    Liu, Yi
    Choi, Dong Soon
    Grandos-Principal, Sergio
    Qian, Wei
    Burey, Lacey
    Wong, Helen
    Rodriguez-Aguayo, Crisitian
    Sood, Anil
    Li, Zheng
    Wong, Stephen
    Weiss, Heidi
    Dave, Bhuvanesh
    Landis, Melissa
    Chang, Jenny C.
    CANCER RESEARCH, 2015, 75
  • [4] GRB7-a novel target in triple-negative breast cancer
    Giricz, Orsi
    Pero, Stephanie C.
    Krag, David N.
    Sparano, Joseph A.
    Kenny, Paraic A.
    CANCER RESEARCH, 2011, 71
  • [5] Novel Therapies for Triple-Negative Breast Cancer
    Nanda, Rita
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (12) : 799 - 801
  • [6] Potential therapeutic target for triple-negative breast cancer
    Gilbert, Judith A.
    LANCET ONCOLOGY, 2012, 13 (08): : E330 - E330
  • [7] BRAF: An emerging target for triple-negative breast cancer
    Albanell, Joan
    Elvin, Julia Andrea
    Ali, Siraj Mahamed
    Schrock, Alexa Betzig
    Chung, Jon
    Vergilio, Jo-Anne
    Suh, James
    Ramkissoon, Shakti
    Severson, Eric Allan
    Daniel, Sugganth
    Miller, Vincent A.
    Stephens, Philip J.
    Gay, Laurie M.
    Ross, Jeffrey S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [8] (+)-Dehydroabietylamine derivatives target triple-negative breast cancer
    Ling, Taotao
    Tran, My
    Gonzalez, Miguel A.
    Gautam, Lekh Nath
    Connelly, Michele
    Wood, Rachael K.
    Fatima, Iram
    Miranda-Carboni, Gustavo
    Rivas, Fatima
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 102 : 9 - 13
  • [9] CDC20 is a novel therapeutic target in triple-negative breast cancer
    Sharma, Jayesh K.
    Alluri, Prasanna
    Udden, Nashir
    CANCER RESEARCH, 2020, 80 (16)
  • [10] CD74: a potential novel target for triple-negative breast cancer
    Tian, Buxian
    Zhang, Yuhong
    Li, Nan
    Liu, Xuewen
    Dong, Jianfeng
    TUMOR BIOLOGY, 2012, 33 (06) : 2273 - 2277
12345